Multidomain Intervention to Prevent Disability in Elders (MINDED)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02082171 |
Recruitment Status :
Completed
First Posted : March 10, 2014
Last Update Posted : September 1, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Physical Frailty Physical Disability Mobility Disability | Other: Multidomain intervention | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 210 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Prevention |
Official Title: | Multidomain Intervention to Prevent Disability in Elders |
Actual Study Start Date : | October 16, 2013 |
Actual Primary Completion Date : | January 2016 |
Actual Study Completion Date : | January 27, 2016 |
Arm | Intervention/treatment |
---|---|
No Intervention: Control group | |
Experimental: Intervention group
Comprehensive geriatric assessment followed by multi-domain preventive intervention
|
Other: Multidomain intervention
Multidomain preventive intervention designed by a multidisciplinary team on the basis of results of a comprehensive geriatric assessment |
- 400-meter walk test [ Time Frame: 12 months ]Incident inability to complete the 400-meter walk test in the two randomization groups
- Participants' adherence/retention to the intervention protocol and control groups [ Time Frame: 12 months ]Participants' adherence/retention to the intervention protocol
- Intercurrent illnesses rates [ Time Frame: 12 months ]Intercurrent illnesses rates in the two randomization groups
- Serious fall injuries [ Time Frame: 12 months ]Incident fall injuries occurred in the two randomization groups
- Hospitalizations and institutionalization rates [ Time Frame: 12 months ]Incidence of acute care hospitalizations and nursing home admissions in the two randomization groups
- Mortality [ Time Frame: 12 months ]Overall mortality rate in the two randomization groups
- Health-related quality of life [ Time Frame: 12 months ]Modifications of health-related quality of life in the two randomization groups
- Body composition modifications [ Time Frame: 12 months ]Body composition modifications (assessed using bioimpedance analysis) in the two randomization groups
- Modification of Pain [ Time Frame: 12 months ]Modification of pain symptoms in the two randomization groups
- Fatigue [ Time Frame: 12 months ]Modification of the fatigue symptom in the two randomization groups

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 60 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age of 60 years and older;
- Willingness to be randomized to either treatment group;
- Pre-frailty or frailty status according to the phenotype described by Fried and colleagues
Exclusion Criteria:
- Failure to provide informed consent;
- Inability to complete a 400-meter walk test (primary outcome of the study);
- Living in nursing home;
- Living outside of the area of interest, or planning to move out of the area in next 3 years, or planning to leave the area for more than 3 months during the next year;
- Relevant cognitive impairment (defined as a known diagnosis of dementia);
- Severe progressive, degenerative neurologic disease (e.g., multiple sclerosis);
- Severe rheumatologic or orthopaedic diseases (e.g., awaiting joint replacement);
- Terminal illness with life expectancy less than 12 months;
- Severe pulmonary disease (e.g., oxygen therapy or chronic use of steroids);
- Severe cardiac disease (e.g., New York Heart Association Class III or IV heart failure, clinically significant aortic stenosis, history of cardiac arrest, uncontrolled angina);
- Other significant comorbid conditions that would impair the ability to participate in the multidomain intervention (e.g., renal failure on hemodialysis, severe psychiatric disorder, excessive alcohol use). To be noted: persons with depression will not be excluded.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02082171
France | |
Centre de Rééducation Fonctionnelle "La Roseraie" | |
Montfaucon, France, 46240 |
Principal Investigator: | Matteo Cesari, MD, PhD | Inserm UMR1027, Université de Toulouse III Paul Sabatier, Toulouse, France |
Responsible Party: | Institut National de la Santé Et de la Recherche Médicale, France |
ClinicalTrials.gov Identifier: | NCT02082171 |
Other Study ID Numbers: |
C12-55 2013-A00380-45 ( Registry Identifier: IDRCB ) |
First Posted: | March 10, 2014 Key Record Dates |
Last Update Posted: | September 1, 2021 |
Last Verified: | August 2021 |
older adults physical disability multidomain intervention prevention |
pilot study frailty mobility comprehensive geriatric assessment |
Frailty Pathologic Processes |